Titre : Kringles

Kringles : Questions médicales fréquentes

Termes MeSH sélectionnés :

Endoglin
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Kringles : Questions médicales les plus fréquentes", "headline": "Kringles : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Kringles : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-24", "dateModified": "2025-03-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Kringles" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Éléments structuraux des protéines", "url": "https://questionsmedicales.fr/mesh/D000072416", "about": { "@type": "MedicalCondition", "name": "Éléments structuraux des protéines", "code": { "@type": "MedicalCode", "code": "D000072416", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G02.111.570.820.709.275" } } }, "about": { "@type": "MedicalCondition", "name": "Kringles", "alternateName": "Kringles", "code": { "@type": "MedicalCode", "code": "D018082", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Liujiao Bian", "url": "https://questionsmedicales.fr/author/Liujiao%20Bian", "affiliation": { "@type": "Organization", "name": "College of Life Science, Northwest University, Xi'an 710069, Shaanxi, China. Electronic address: bianliujiao@sohu.com." } }, { "@type": "Person", "name": "Byung Kwan Jin", "url": "https://questionsmedicales.fr/author/Byung%20Kwan%20Jin", "affiliation": { "@type": "Organization", "name": "4 Departments of Biochemistry and Molecular Biology, and Neuroscience Graduate School, School of Medicine, Kyung Hee University, Seoul, Korea." } }, { "@type": "Person", "name": "Jae Yeong Jeong", "url": "https://questionsmedicales.fr/author/Jae%20Yeong%20Jeong", "affiliation": { "@type": "Organization", "name": "3 Department of Predictive Model Research Center, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Daejeon, Korea." } }, { "@type": "Person", "name": "Stefan Coassin", "url": "https://questionsmedicales.fr/author/Stefan%20Coassin", "affiliation": { "@type": "Organization", "name": "Institute of Genetic Epidemiology, Medical University of Innsbruck, Schoepfstrasse 41, 6020, Innsbruck, Austria. Electronic address: Stefan.Coassin@i-med.ac.at." } }, { "@type": "Person", "name": "Florian Kronenberg", "url": "https://questionsmedicales.fr/author/Florian%20Kronenberg", "affiliation": { "@type": "Organization", "name": "Institute of Genetic Epidemiology, Medical University of Innsbruck, Schoepfstrasse 41, 6020, Innsbruck, Austria." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Alteration in sB7-H4 Serum Levels and Placental Biomarker Expression after Therapeutic Plasma Exchange in Early-Onset Preeclampsia Patients.", "datePublished": "2024-10-15", "url": "https://questionsmedicales.fr/article/39456867", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms252011082" } }, { "@type": "ScholarlyArticle", "name": "Improving Hereditary Hemorrhagic Telangiectasia Molecular Diagnosis: A Referral Center Experience.", "datePublished": "2023-03-22", "url": "https://questionsmedicales.fr/article/36981042", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/genes14030772" } }, { "@type": "ScholarlyArticle", "name": "[Dysfunction of endothelial BMP-9 signaling in pulmonary vascular disease].", "datePublished": "2023-02-23", "url": "https://questionsmedicales.fr/article/36828679", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.rmr.2023.01.017" } }, { "@type": "ScholarlyArticle", "name": "Association of cord blood Ang-1 and sCD105 levels with bronchopulmonary dysplasia in preterm infants.", "datePublished": "2024-07-15", "url": "https://questionsmedicales.fr/article/39010003", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12887-024-04932-7" } }, { "@type": "ScholarlyArticle", "name": "CD105 in the progression and therapy of renal cell carcinoma.", "datePublished": "2023-07-26", "url": "https://questionsmedicales.fr/article/37499740", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.canlet.2023.216327" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes chimiques", "item": "https://questionsmedicales.fr/mesh/D055598" }, { "@type": "ListItem", "position": 3, "name": "Phénomènes biochimiques", "item": "https://questionsmedicales.fr/mesh/D001669" }, { "@type": "ListItem", "position": 4, "name": "Conformation moléculaire", "item": "https://questionsmedicales.fr/mesh/D008968" }, { "@type": "ListItem", "position": 5, "name": "Conformation des protéines", "item": "https://questionsmedicales.fr/mesh/D011487" }, { "@type": "ListItem", "position": 6, "name": "Éléments structuraux des protéines", "item": "https://questionsmedicales.fr/mesh/D000072416" }, { "@type": "ListItem", "position": 7, "name": "Kringles", "item": "https://questionsmedicales.fr/mesh/D018082" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Kringles - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Kringles", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Kringles", "description": "Comment diagnostiquer une anomalie des Kringles ?\nQuels tests sont utilisés pour évaluer les Kringles ?\nLes Kringles peuvent-ils être visualisés par imagerie ?\nQuels marqueurs biologiques sont associés aux Kringles ?\nLes tests génétiques sont-ils fiables pour les Kringles ?", "url": "https://questionsmedicales.fr/mesh/D018082?mesh_terms=Endoglin&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Kringles", "description": "Quels symptômes sont liés aux anomalies des Kringles ?\nLes anomalies des Kringles provoquent-elles des douleurs ?\nLes symptômes des Kringles sont-ils toujours visibles ?\nLes anomalies des Kringles affectent-elles la circulation sanguine ?\nLes symptômes des Kringles varient-ils selon les individus ?", "url": "https://questionsmedicales.fr/mesh/D018082?mesh_terms=Endoglin&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Kringles", "description": "Comment prévenir les complications liées aux Kringles ?\nL'exercice physique aide-t-il à prévenir les problèmes de Kringles ?\nUne alimentation spécifique peut-elle aider ?\nLes anticoagulants préventifs sont-ils recommandés ?\nLe dépistage précoce est-il important ?", "url": "https://questionsmedicales.fr/mesh/D018082?mesh_terms=Endoglin&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Kringles", "description": "Quels traitements sont disponibles pour les anomalies des Kringles ?\nLes transfusions sanguines sont-elles nécessaires ?\nLa chirurgie est-elle une option pour les anomalies des Kringles ?\nLes traitements sont-ils personnalisés pour chaque patient ?\nLes traitements des Kringles sont-ils efficaces ?", "url": "https://questionsmedicales.fr/mesh/D018082?mesh_terms=Endoglin&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Kringles", "description": "Quelles sont les complications possibles des anomalies des Kringles ?\nLes complications peuvent-elles être mortelles ?\nComment gérer les complications des Kringles ?\nLes complications sont-elles prévisibles ?\nLes complications des Kringles nécessitent-elles une hospitalisation ?", "url": "https://questionsmedicales.fr/mesh/D018082?mesh_terms=Endoglin&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Kringles", "description": "Quels sont les facteurs de risque des anomalies des Kringles ?\nL'âge influence-t-il le risque d'anomalies des Kringles ?\nLe mode de vie affecte-t-il le risque ?\nLes maladies chroniques sont-elles un facteur de risque ?\nLe stress a-t-il un impact sur le risque ?", "url": "https://questionsmedicales.fr/mesh/D018082?mesh_terms=Endoglin&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie des Kringles ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par des tests génétiques et des analyses protéomiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les Kringles ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de coagulation et des dosages protéiques spécifiques sont utilisés." } }, { "@type": "Question", "name": "Les Kringles peuvent-ils être visualisés par imagerie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, les Kringles ne sont pas visibles par imagerie, mais leurs effets peuvent l'être." } }, { "@type": "Question", "name": "Quels marqueurs biologiques sont associés aux Kringles ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme le fibrinogène et les facteurs de coagulation sont associés." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils fiables pour les Kringles ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques sont fiables pour identifier les mutations liées aux Kringles." } }, { "@type": "Question", "name": "Quels symptômes sont liés aux anomalies des Kringles ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles de la coagulation, des hémorragies ou des thromboses." } }, { "@type": "Question", "name": "Les anomalies des Kringles provoquent-elles des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs peuvent survenir en raison de thromboses ou d'hémorragies." } }, { "@type": "Question", "name": "Les symptômes des Kringles sont-ils toujours visibles ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Non, certains symptômes peuvent être asymptomatiques et ne se manifester qu'à l'examen." } }, { "@type": "Question", "name": "Les anomalies des Kringles affectent-elles la circulation sanguine ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des problèmes de circulation sanguine, comme des caillots." } }, { "@type": "Question", "name": "Les symptômes des Kringles varient-ils selon les individus ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de la gravité et du type d'anomalie." } }, { "@type": "Question", "name": "Comment prévenir les complications liées aux Kringles ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut un suivi médical régulier et un traitement préventif approprié." } }, { "@type": "Question", "name": "L'exercice physique aide-t-il à prévenir les problèmes de Kringles ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la circulation et réduire les risques de thrombose." } }, { "@type": "Question", "name": "Une alimentation spécifique peut-elle aider ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée, riche en oméga-3, peut aider à la santé cardiovasculaire." } }, { "@type": "Question", "name": "Les anticoagulants préventifs sont-ils recommandés ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anticoagulants peuvent être prescrits pour prévenir les complications thromboemboliques." } }, { "@type": "Question", "name": "Le dépistage précoce est-il important ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage précoce des anomalies peut aider à prévenir des complications graves." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les anomalies des Kringles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des anticoagulants et des thérapies ciblées selon le cas." } }, { "@type": "Question", "name": "Les transfusions sanguines sont-elles nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, dans certains cas, des transfusions peuvent être nécessaires pour corriger les anomalies." } }, { "@type": "Question", "name": "La chirurgie est-elle une option pour les anomalies des Kringles ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie peut être envisagée dans des cas graves, comme des thromboses récurrentes." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés pour chaque patient ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements sont souvent personnalisés en fonction des besoins individuels." } }, { "@type": "Question", "name": "Les traitements des Kringles sont-ils efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être très efficaces pour gérer les symptômes et prévenir les complications." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des anomalies des Kringles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des thromboses, des embolies et des hémorragies sévères." } }, { "@type": "Question", "name": "Les complications peuvent-elles être mortelles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines complications, comme les embolies pulmonaires, peuvent être mortelles." } }, { "@type": "Question", "name": "Comment gérer les complications des Kringles ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La gestion inclut des traitements médicaux et parfois des interventions chirurgicales." } }, { "@type": "Question", "name": "Les complications sont-elles prévisibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être prévisibles avec un suivi médical approprié." } }, { "@type": "Question", "name": "Les complications des Kringles nécessitent-elles une hospitalisation ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications graves peuvent nécessiter une hospitalisation pour traitement intensif." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque des anomalies des Kringles ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, l'obésité et le tabagisme." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'anomalies des Kringles ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge en raison de la dégradation des mécanismes de coagulation." } }, { "@type": "Question", "name": "Le mode de vie affecte-t-il le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque." } }, { "@type": "Question", "name": "Les maladies chroniques sont-elles un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme le diabète et l'hypertension augmentent le risque d'anomalies." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter la coagulation et augmenter le risque d'anomalies." } } ] } ] }

Sources (63 au total)

Improving Hereditary Hemorrhagic Telangiectasia Molecular Diagnosis: A Referral Center Experience.

Hereditary hemorrhagic telangiectasia (HHT) is a rare vascular disease inherited in an autosomal dominant manner. Disease-causing variants in endoglin (... Gene panel sequencing of genes associated with HHT and other arteriovenous malformation-related syndromes was performed. To evaluate the effect of the splice site variants, cDNA analysis of... three novel splice site variants were identified in... RNA analysis should be performed to assess and/or confirm the impact of variants on splicing. The molecular diagnosis of HHT patients is crucial to allow family screening and accurate genetic counseli...

Association of cord blood Ang-1 and sCD105 levels with bronchopulmonary dysplasia in preterm infants.

To investigate the relationship between cord blood levels of Angiopoietin-1 (Ang-1) and S-endoglin (sCD105) and bronchopulmonary dysplasia (BPD) in preterm infants.... Sixty-one preterm infants admitted to the neonatal intensive care unit of the study hospital between July 2021 and September 2022 were included. Cord blood was collected after the birth of premature i... In the study, there were 20 preterm infants with BPD (32.8%) and 41 preterm infants with non-BPD (67.2%). Ang-1 concentration levels were lower in the BPD group than in the non-BPD group (7105.43 (561... Our study indicated that Ang-1 levels in the cord blood of preterm infants may be associated the risk of BPD. In the future, we will continue to conduct study with large samples....

Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease.

Hepatitis B virus (HBV) infection remains a significant global burden, especially for patients with chronic kidney disease (CKD) receiving hemodialysis. Three doses of HepB-CpG (HEPLISAV-B® vaccine) i... HBV-19 is a multicenter, open-label, phase 3b trial of adults with CKD who previously received a complete series of HepB-CpG or HepB-Eng in the HBV-17 trial. Participants were assigned to seroprotecti... 147 participants were enrolled; 66.7 % were men, median age was 65.0 years, and 83.7 % were white. The durability of seroprotection in participants with CKD was similar in those who received HepB-CpG ... Due to the higher antibody levels induced by HepB-CpG in participants with CKD, seroprotection against HBV may be expected to persist longer than that induced by HepB-Eng.... gov: NCT01282762....

Microvascular density and tumor budding in oral squamous cell carcinoma.

Oral squamous cell carcinoma (OSCC) is the most prevalent malignant head and neck tumor, excluding the nonmelanoma skin cancer. Despite recent advances in the diagnosis and treatment, the disease's mo... One hundred and fifty [150] samples of OSCC were subjected to immunohistochemistry to assess the intensity of tumor budding (by immunostaining for multi-cytokeratin) and MVD (by immunostaining for CD3... There were no differences in MVD, assessed by immunostaining for CD34 or CD105, concerning clinicopathological characteristics such as sex, age, tobacco smoking, tumor location and tumor size (p > 0.0... The higher MVD in the budding area may be an additional indication that this is a peculiar region of the tumor, associated with biological phenomena related to tumor progression....

Response of TGF-β isoforms in epithelial-mesenchymal transition of enamel epithelial cells.

During enamel formation, transforming growth factor-beta (TGF-β) isoforms exhibit different activities for gene expression, apoptosis, and endocytosis. This study aimed to investigate the differential... Using a mouse enamel epithelial cell line (mHAT9d) cultured in the presence of each TGF-β isoform, (1) the morphological changes in EMT were explored, (2) EMT-related genes were analyzed by next-gener... EMT was observed in mHAT9d cultured in the presence of TGF-β1 and β3 but not TGF-β2. The expression of both epithelial and mesenchymal marker genes was observed in mHAT9d exhibiting EMT. NGS analysis ... We propose that in TGF-β-stimulated enamel epithelial cells, EMT mainly occurred via the Rho signaling pathway, and the differences in response across TGF-β isoforms were due to their endoglin-mediate...